A new trading day began On Friday, with Aldeyra Therapeutics Inc (NASDAQ: ALDX) stock price down -3.61% from the previous day of trading, before settling in for the closing price of $4.99. ALDX’s price has ranged from $1.14 to $7.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.99% over the past five years. Meanwhile, its annual earnings per share averaged 14.47%. With a float of $58.15 million, this company’s outstanding shares have now reached $60.05 million.
Let’s look at the performance matrix of the company that is accounted for 9 employees. In terms of profitability, gross margin is 49.89%, operating margin of -25007.82%, and the pretax margin is -23596.19%.
Aldeyra Therapeutics Inc (ALDX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Aldeyra Therapeutics Inc is 2.92%, while institutional ownership is 56.94%. The most recent insider transaction that took place on Apr 03 ’25, was worth 4,828,000. In this transaction 10% Owner of this company sold 3,400,000 shares at a rate of $1.42, taking the stock ownership to the 5,875,851 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Chief Development Officer sold 16,041 for $4.74, making the entire transaction worth $75,975. This insider now owns 236,771 shares in total.
Aldeyra Therapeutics Inc (ALDX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.47% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Here are Aldeyra Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach 0.13 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Aldeyra Therapeutics Inc (NASDAQ: ALDX) saw its 5-day average volume 1.08 million, a negative change from its year-to-date volume of 1.22 million. As of the previous 9 days, the stock’s Stochastic %D was 18.90%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 60.56%, which indicates a significant increase from 40.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.76, while its 200-day Moving Average is $4.54.
